Skip to main content
SpringerLink
Log in

Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies

  • Published:
Cell Biophysics Aims and scope Submit manuscript

Abstract

The aim of the investigation was to study directly the IL-2 receptor (IL-2 R) and its subunits, p55 and p75 chains, either membrane-bound or soluble, on PBMC of patients with solid malignancies and, indirectly, the same patients’ PBMC ability to produce IL-2. Fifty-eight cancer patients, 29 men and 29 women, were studied: their mean age was 57.3 yr, range 35–79. Twenty-two healthy age-sex-matched subjects served as controls. The tumors were the most common and the most representative among human cancers, i.e., breast, lung, head and neck, digestive tract and liver, prostate and gynecologic cancers: they were generally in advanced stages and in 23 cases metastatic. The PBMC proliferative response to PHA, PHA plus IL-2, and IL-2 was evaluated along with the response to PHA in the presence of anti-p55, anti-p75 monoclonal antibodies, or both. Moreover, membrane-bound IL-2 R (p55 and p75 chains) on PHA-stimulated PBMC was detected, along with soluble IL-2 R in the serum and in the culture supernatants. The conclusions suggest that in solid malignancies: the membrane-bound IL-2 Rs, both p55 and p75 chains, are expressed normally, there is an high serum level of soluble IL-2 R, there is a normal release of soluble IL-2 R in culture, and there is an indirect evidence of a lack of IL-2 production. Therefore, no primary impairment of IL-2 R was found in solid tumors. Moreover, in our study we have found no difference in any parameter studied between patients with and patients without metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morgan, D. A., Ruscetti, F. W., and Gallo, R. C. (1976) Selective in vitro growth of T-lymphocytes from normal human bone marrows.Science 193, 1007, 1008.

    Article  PubMed  CAS  Google Scholar 

  2. Smith, K. A. (1988) Interleukin-2: inception, impact and implications.Science 240, 1169–1176.

    Article  PubMed  CAS  Google Scholar 

  3. Greene, W. C. and Leonard, W. J. (1986) The human interleukin-2 receptor.Ann. Rev. Immunol. 4, 69–95.

    Article  CAS  Google Scholar 

  4. Robb, R. J., Munck, A., and Smith, K. A. (1983) T-cell growth factor receptors: quantitation, specificity, and biological relevance.J. Exp. Med. 154, 1455–1474.

    Article  Google Scholar 

  5. Colamonici, O. R., Neckers, L. M., and Rosolen, A. (1990) α-subunits of the IL-2-receptors is detected in low, intermediate, and high-affinity IL-2-receptor-bearing cells.J. Immunol. 145, 155–160.

    PubMed  CAS  Google Scholar 

  6. Dukovich, M., Wano, Y., Bich-Thuy, L. T., Katz, P., Cullen, B. R., Kehrl, J. H., and Greene, W. C. (1987) A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptor.Nature (Lond.) 327, 518–522.

    Article  CAS  Google Scholar 

  7. Robb, R. J. and Greene, W. C. (1987) Internalization of interleukin-2 is mediated by the beta-chain of the high-affinity interleukin-2 receptor.J. Exp. Med. 165, 1201–1206.

    Article  PubMed  CAS  Google Scholar 

  8. Robb, R. J., Rusk, C. M., Yodoi, J., and Greene, W. C., (1987) Interleukin-2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.Proc. Natl. Acad. Sci. USA. 84, 2002–2006.

    Article  PubMed  CAS  Google Scholar 

  9. Sharon, M., Klausner, R. D., Cullen, B. R., Chizzonite, R., and Leonard, W. (1986) Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions.Science (Wash.) 234, 859–863.

    Article  CAS  Google Scholar 

  10. Siegel, J. P., Sharon, M., Smith, P. L., and Leonard, W. J. (1987) The IL-2 receptor beta-chain of the high-affinity interleukin-2 receptor.Science (Wash.) 238, 75–78.

    Article  CAS  Google Scholar 

  11. Smith, K. A. (1987) The two-chain structure of high-affinity IL-2 receptors.Immunol. Today 8, 11–13.

    Article  CAS  Google Scholar 

  12. Tsudo, M., Goldman, C. K., Bongiovanni, K. F., Chan, W. C., Winton, E. F., Yagita, M., Grimm, E. A., and Waldmann, T. A. (1987) The p75 peptide is the receptor for interleukin-2 expressed on large granular lymphocytes and is responsible for the interleukin-2 activation of these cells.Proc. Natl. Acad. Sci. USA 84, 5394–5398.

    Article  PubMed  CAS  Google Scholar 

  13. Tsudo, M., Kozak, R. W., Goldman, C. K., and Waldmann, T. A. (1986) Demonstration of a non-Tac peptide that binds interleukin-2 receptor complex.Proc. Natl. Acad. Sci. USA 83, 9694–9698.

    Article  PubMed  CAS  Google Scholar 

  14. Wang, H. M. and Smith, K. A. (1987) The interleukin-2 receptor: functional consequences of its bimolecular structure.J. Exp. Med. 166, 1055–1069.

    Article  PubMed  CAS  Google Scholar 

  15. Robb, R. J., Greene, W. C., and Rusk, C. M. (1984) Low and high-affinity cellular receptors for interleukin-2: implications for the level of Tac antigen.J. Exp. Med. 160, 1126–1146.

    Article  PubMed  CAS  Google Scholar 

  16. Korsmeyer, S. J., Greene, W. C., Cossman, J., Hsu, S. M., Jensen, J. P., Neckers, L. M., Marshall, S. L., Bakshi, A., Depper, J. M., Leonard, W. J., Jaffe, E. S., and Waldmann, T. A. (1983) Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.Proc. Natl. Acad. Sci. USA 80, 4522–4526.

    Article  PubMed  CAS  Google Scholar 

  17. Jung, L. K. L., Hara, T., and Fu, S. M. (1984) Detection and functional studies of p60–65 (Tac antigen) on activated human B cells.J. Exp. Med. 160, 1597–1602.

    Article  PubMed  CAS  Google Scholar 

  18. Tsudo, M., Uchiyama, T., and Uchino, H. (1984) Expression of Tac antigen on activated normal human B cells.J. Exp. Med. 160, 612–617.

    Article  PubMed  CAS  Google Scholar 

  19. Waldmann, T. A., Goldman, C. K., Robb, R. J., Depper, J. M., Leonard, W. J., Sharrow, S. O., Bongiovanni, K. G., Korsmeyer, S. J., and Greene, W. C. (1984) Expression of interleukin-2 receptors on activated human B cells.J. Exp. Med. 160, 1450–1466.

    Article  PubMed  CAS  Google Scholar 

  20. Pizzolo, G., Chilosi, M., Vinante, F., Dazzi, F., Lestani, M., Perona, G., Benedetti, F., Todeschini, G., Vincenzi, C., Trentin, L., and Semenzato, G. (1987) Soluble Interleukin-2 receptors in the serum of patients with Hodgkin’s disease.Br. J. Cancer 55, 427–428.

    PubMed  CAS  Google Scholar 

  21. Fox, D. A. Hussey, R. E., Fitzgerald, K. A., Bensussan, A., Daley, J. F., Schlossman, S. F., and Reinherz, E. L. (1985) Activation of human thymocytes via the 50 kDa T11 sheep erythrocyte binding protein induces the expression of interleukin-2 receptors on both T3+ and T3− populations.J. Immunol. 134, 330–335.

    PubMed  CAS  Google Scholar 

  22. Herrmann, F., Cannistra, S. A., Levine, H., and Griffin, J. D. (1985) Expression of interleukin-2 receptors and binding of interleukin-2 by gamma interferon-induced human leukemic and normal monocytic cells.J. Exp. Med. 162, 1111–1116.

    Article  PubMed  CAS  Google Scholar 

  23. Uchiyama, T. (1988) Abnormal interleukin-2 receptor expression in adult T cells leukemia, inInterleukin-2 (Smith, K. A., ed.), Academic, San Diego, CA, pp. 1–35.

    Google Scholar 

  24. Foà, R., Giovarelli, M., Jemma, C., Fierro, M. T., Lusso, P., Ferrando, M. L., Lauria, F., and Forni, G. (1985) Interleukin-2 (IL-2) and interferon-gamma production by T-lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL-2 is absorbed by the neoplastic B cell population.Blood 66, 614–619.

    PubMed  Google Scholar 

  25. Lantz, O., Grillot-Courvalin, C., Schmitt, C., Fermand, J. P., and Brouet, J. C. (1985) Interleukin-2-induced proliferation of leukemic human B cells.J. Exp. Med.,161, 1225–1230.

    Article  PubMed  CAS  Google Scholar 

  26. Pizzolo, G., Chilosi, M., and Semenzato, G. (1987) The soluble interleukin-2 receptor in hematological disorders.Br. J. Hematol. 67, 377–380.

    Article  CAS  Google Scholar 

  27. Tsang, K. Y., Fudenberg, H. H., Galbraith, G. M. P., Donnelley, R. P., Bishop, L. R., and Koopmann, W. R. (1985) Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.J. Clin. Invest. 75, 1538–1544.

    Article  PubMed  CAS  Google Scholar 

  28. Malkowsky, M., Jira, M., Gao, L., Loveland, B., Malkovska, V., Dalgleish, A. G., and Webster, A. D. (1986) Reduced expression of interleukin-2 receptors in hypogammaglobulinaemia: a possible cause of higher cancer incidence.Lancet,i, 1442–1443.

    Article  Google Scholar 

  29. Rubin, L. A., Kurman, C. C., Fritz, M. E., Biddison, W. E., Boutin, B., Yarchoan, R., and Nelson, D. L. (1985) Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro.J. Immunol. 135, 3172–3177.

    PubMed  CAS  Google Scholar 

  30. Greene, W. C., Leonard, W. J., Depper, J. M., Nelson, D. L., and Waldmann, T. A. (1986) The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses.Ann. Int. Med. 105, 560–572.

    PubMed  CAS  Google Scholar 

  31. Rubin, L. A., Jay, G., and Nelson, D. L. (1986) The released interleukin-2 receptor binds interleukin-2 efficiently.J. Immunol. 137, 3841–3844.

    PubMed  CAS  Google Scholar 

  32. Chilosi, M., Pizzolo, G., Semenzato, G., and Cetto, G. L. (1986) Detection of a soluble form of the receptor for interleukin-2 in the serum of patients with hairy cell leukaemia.Int. J. Biol. Markers 1, 101–104.

    PubMed  CAS  Google Scholar 

  33. Pizzolo, G., Chilosi, M., Ambrosetti, A., Agostini, C., Maisciarelli, M., Trentin, L., Zambello, R., Lestani, M., Vinante, F., Dazzi, F., Cetto, G., and Semenzato, G. (1986) Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of alpha-interferon therapy on clinical parameters and on natural killer in vitro activity.Blood 68 (Suppl. 1), 228a.

    Google Scholar 

  34. Semenzato, G., Foà, R., Agostini, C., Zambello, R., Trentin, L., Vinante, F., Benedetti, F., Chilosi, M., and Pizzolo, G. (1987) High serum levels of soluble interleukin-2 receptor (s IL-2 R) in patients with B chronic lymphocytic leukemia (B-CLL).Blood 70, 396–400.

    PubMed  CAS  Google Scholar 

  35. Mantovani, G., Coiana, A., Massidda, A., Proto, E., Floris, C., Pusceddu, G., Maccio, A., and Del Giacco, G. S. (1988) Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2 and IL-2 receptor expression in patients with advanced cancer.Cancer Detect. Prev. 12, 149–159.

    PubMed  CAS  Google Scholar 

  36. Zielinski, C. C., Muller, C. H., Tichatschek, E., and Aiginger P. (1989) Decreased production of soluble interleukin-2 receptor by phytoheamag-glutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.Br. J. Cancer 60, 712–714.

    PubMed  CAS  Google Scholar 

  37. Mantovani, G., Coiana, A., Cossu, F., Floris, C., Proto, E., Maccio, A., Pisano, G., Taglieri, G., Pusceddu, G., and Del Giacco, G. S. (1986) Peripheral blood lymphocytes response to exogenous interleukin-2 by PHA-prestimulated and non-PHA-prestimulated cells in patients with cancer.Tumori 72, 375–382.

    PubMed  CAS  Google Scholar 

  38. Mantovani, G., Coiana, A., Massidda, A., Proto, E., Floris, C., Maccio, A., Pusceddu, G., and Del Giacco, G. S. (1987) Interleukin-2 (IL-2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL-2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.Diagn. Clin. Immunol. 5, 104–111.

    PubMed  CAS  Google Scholar 

  39. Cantrell, D. A. and Smith, K. A. (1983) Transient expression of interleukin-2 receptors: consequences for T-cell growth.J. Exp. Med. 158, 1895–1911.

    Article  PubMed  CAS  Google Scholar 

  40. Smith, K. A. (1988) Interleukin-2: a 10 years perspective, inInterleukin-2 (Smith, K. A., ed.), Academic, San Diego, CA, pp. 1–35.

    Google Scholar 

  41. Dower, S. K., Smith, C. A., and Park, L. S. (1990) Human cytokine receptors.J. Clin. Immunol. 10, 289–299.

    Article  PubMed  CAS  Google Scholar 

  42. Ambrosetti, A., Semenzato, G., Prior, M., Chilosi, M., Vinante, F., Vincenzi, C., Zanotti, R., Trentin, L., Portuese, A., Menestrina, F., Perona, G., Agostini, C., Todeschini, G., and Pizzolo, G. (1989) Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk.Br. J. Haematol. 73, 181–186.

    Article  PubMed  CAS  Google Scholar 

  43. Chilosi, M., Semenzato, G., Vinante, F., Menestrina, F., Piazzola, E., Facchiatti, V., Sabbioni, R., Zanotti, R., and Pizzolo, G. (1989) Increased levels of soluble interleukin-2 receptor in non-Hodgkin’s lymphomas.Am. J. Clin. Path. 92, 186–191.

    PubMed  CAS  Google Scholar 

  44. Romagnani, S., Rossi Ferrini, P. L., and Ricci, M. (1985) The immune derangement in Hodgkin’s disease.Semin. Haematol. 22, 41–55.

    CAS  Google Scholar 

  45. Rosenberg, S. A. (1988) Immunotherapy of cancer using interleukin-2: current status and future prospects.Immunol. Today 9, 58–62.

    Article  PubMed  CAS  Google Scholar 

  46. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Avis, F. P., Leitman, S., Linehan, W. M., Robertson, C. N., Lee, R. E., Rubin, J. T., Seipp, C. A., Simpson, C. G., and White, D. E. (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.N. Engl. J. Med. 316, 889–897.

    PubMed  CAS  Google Scholar 

  47. Voss, S. D., Hank, J. A., Nobis, C. A., Fisch, P., Sosman, J. A., and Sondel, P. M. (1989) Serum levels of the low-affinity interleukin-2 receptor molecule (Tac) during IL-2 therapy reflect systemic lymphoid mass activation.Cancer Immunol. Immunother. 29, 261–269.

    Article  PubMed  CAS  Google Scholar 

  48. West, W. H., Tauer, K. W., Yannelli, J. R., Marshall, G. D., Orr, D. W., Thurman, G. B., and Oldham, R. K. (1987) Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.N. Engl. J. Med. 316, 898–905.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, University of Cagliari, Cagliari, Italy

    Giovanni Mantovani, Antonio Macciò, Giorgio Astara, Luciana Contini, Silvia Esu, Sabrina Littera & Paola Lai

  2. Department of Medical Pathology and Clinical Immunology, University of Cagliari, Cagliari, Italy

    Vincenzo Arangino & G. Sergio Del Giacco

  3. Department of Internal Medicine, University of Cagliari, Cagliari, Italy

    Angelo Balestrieri

  4. Department of Otolaryngology, University of Cagliari, Cagliari, Italy

    Ernesto Proto

  5. “R. Binaghi” Hospital, Cagliari, Italy

    Guido Pusceddu

Authors
  1. Giovanni Mantovani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Macciò
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giorgio Astara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luciana Contini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Silvia Esu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sabrina Littera
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vincenzo Arangino
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paola Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ernesto Proto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Guido Pusceddu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Angelo Balestrieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. G. Sergio Del Giacco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mantovani, G., Macciò, A., Astara, G. et al. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies. Cell Biophysics 22, 79–99 (1993). https://doi.org/10.1007/BF03033868

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033868

Index Entries

Search

Navigation